Hippo Holdings (NYSE: HIPO) insider files to sell 5,000 shares
Rhea-AI Filing Summary
Hippo Holdings Inc. received a notice that an individual security holder plans to sell 5,000 shares of its common stock under Rule 144. The shares were originally acquired as 5,000 restricted stock units from Hippo Holdings Inc. on 12/24/2020. The planned sale is to be executed through Merrill Lynch on the NYSE around 01/09/2026, with an indicated aggregate market value of $157,600 and with 25,335,179 common shares outstanding. The form also reports that the same seller disposed of 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 during the prior three months.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for Hippo Holdings (HIPO) disclose?
The filing discloses that an individual holder intends to sell 5,000 shares of Hippo Holdings Inc. common stock under Rule 144, with the transaction to be executed through Merrill Lynch on the NYSE around 01/09/2026.
How many Hippo Holdings (HIPO) shares are planned to be sold and at what value?
The notice covers a planned sale of 5,000 common shares of Hippo Holdings Inc., with an indicated aggregate market value of $157,600.
How were the Hippo Holdings (HIPO) shares being sold on Form 144 originally acquired?
The 5,000 Hippo Holdings Inc. common shares were acquired on 12/24/2020 as restricted stock units from Hippo Holdings Inc., with the same date listed for acquisition and payment.
What prior sales does the Hippo Holdings (HIPO) Form 144 report for the last 3 months?
The form reports that the same seller previously sold 5,000 common shares of Hippo Holdings Inc. on 12/09/2025, generating $149,100 in gross proceeds.
How many Hippo Holdings (HIPO) shares are outstanding according to this Form 144?
The notice states that there were 25,335,179 Hippo Holdings Inc. common shares outstanding at the time referenced in the filing.
Which broker and exchange are involved in the planned Hippo Holdings (HIPO) share sale?
The planned sale is through Merrill Lynch, located at 555 California St., Floor 18, San Francisco, CA 94104, and the shares are to be sold on the NYSE.